Maralixibat 380 µg/mL Suppliers & Bulk Manufacturers
Available Forms: Oral Solution
Available Strengths: 380 µg/mL
Reference Brands: Livmarli (USA/EU)
Category: Medical Aid
Maralixibat (Livmarli) is used to treat progressive familial intrahepatic cholestasis (PFIC) in pediatric patients. It works by inhibiting the ileal bile acid transporter (IBAT), reducing bile acid reabsorption in the intestine, decreasing systemic bile acid levels, and improving liver function and pruritus (itching) associated with cholestatic liver disease.
Maralixibat — third party manufacturing & bulk supply
Maralixibat 380 µg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Maralixibat is supplied as Oral Solution — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Maralixibat listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Maralixibat →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Maralixibat is used to treat cholestatic pruritus in patients with rare liver diseases, such as Alagille syndrome.
Maralixibat is a small-molecule ileal bile acid transporter (IBAT) inhibitor that reduces bile acid reabsorption in the intestine.
The trade name is Livmarli.
Livmarli is manufactured by Mirum Pharmaceuticals.
The generic name is maralixibat.
The brand name is Livmarli.
It is manufactured in the United States by Mirum Pharmaceuticals.
Related Products
Indocyanine Green
Strength:
25 mg
Form: Injection
Reference Brands: IC-Green (USA), Verdye (USA/EU)
View Details
Hexaminolevulinate Hydrochloride
Strength:
100 mg , 85 mg
Form: Injection
Reference Brands: Cysview (USA), Hexvix (EU)
View Details
Indigotindisulfonate Sodium
Strength:
20 mg/mL, 40 mg/mL
Form: Injection
Reference Brands: Indigo Carmine ((USA), Bludigo (USA)
View Details
Lofexidine Hydrochloride
Strength:
0.18 mg
Form: Tablets
Reference Brands: Lucemyra (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
